Showing 161 - 180 results of 346 for search '"depressive disorders"', query time: 0.06s Refine Results
  1. 161
  2. 162

    Recognition of Depression and Anxiety among Elderly Colorectal Cancer Patients by Amy Y. Zhang, Gregory S. Cooper

    Published 2010-01-01
    “…The findings show that the ICD-9 diagnoses ranged from 1.5% to 1.8% for depressive disorders and 0.8% to 1.2% for anxiety states in the colorectal cancer outpatients, and from 2% to 2.5% for depressive disorders and 1.1% to 1.5% for anxiety states in the noncancer outpatients over five years. …”
    Get full text
    Article
  3. 163

    The burden of depression, anxiety and schizophrenia among the older population in ageing and aged countries: an analysis of the Global Burden of Disease Study 2019 by Wu Hong, Ying Cheng, Yu Fang, Jinxin Zheng, Shiyang Guan, Meiti Wang

    Published 2024-02-01
    “…The ASDR for depressive disorders was consistent with the ASIR but not for anxiety disorders and schizophrenia. …”
    Get full text
    Article
  4. 164

    The psychometric properties of the child anxiety and depression life interference scale (CADLIS) by Maddison O’Gradey-Lee, Alana Jones, Esther Gandhi, Heidi Lyneham, Ronald M. Rapee, Jennifer L. Hudson

    Published 2025-01-01
    “…Abstract Objective Life interference is a key diagnostic feature for anxiety and depressive disorders. Measures focusing on life interference caused by anxiety and depressive disorders in children and adolescents have received minimal attention. …”
    Get full text
    Article
  5. 165

    RESEARCH by Mihai Bran

    Published 2021-09-01
    “…Particularities of suicidal behavior in depressive disorders in young people …”
    Get full text
    Article
  6. 166

    Physical activity and depression by Monika Wojtasik, Katarzyna Żak, Adam Załóg, Maria Nowak, Edyta Pietryszak, Wojciech Kulej, Paulina Szołtek, Rafał Pardela, Marcel Paruzel, Martyna Łęcka

    Published 2025-02-01
    “… This article aims to present the significance of physical activity as a key element in the prevention and therapy of depressive disorders. Through a review of the latest scientific research findings, the article focuses on the role of regular physical activity in reducing the risk of depressive disorders and its effectiveness in the therapeutic process. …”
    Get full text
    Article
  7. 167
  8. 168

    Symptom-based depression subtypes: brain dynamic specificity and its association with gene expression profiles by Qunjun Liang, Zhifeng Zhou, Shengli Chen, Shiwei Lin, Xiaoshan Lin, Ying Li, Yingli Zhang, Bo Peng, Gangqiang Hou, Yingwei Qiu

    Published 2025-01-01
    “…Abstract At least 227 combinations of symptoms meet the criteria for Major Depressive Disorder (MDD). However, in clinical practice, patients consistently present symptoms in a regular rather than random manner, and the neural basis underlying the MDD subtypes remains unclear. …”
    Get full text
    Article
  9. 169
  10. 170

    Differences between SSRI and SNRI in depression treatment by Mateusz Grego, Katarzyna Grego, Łukasz Stojak, Dariusz Popiela, Karina Urbańska, Filip Kwiatkowski, Mateusz Baczewski, Witold Czyż

    Published 2025-01-01
    “… Introduction Depressive disorders represent a significant health problem worldwide. …”
    Get full text
    Article
  11. 171

    Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment by Huijuan Liao, David S. Rosenthal, Salini C. Kumar

    Published 2023-01-01
    “…Mental health issues, especially depressive disorders, are major burdens to the health care systems. …”
    Get full text
    Article
  12. 172

    A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain by Christopher Robinson, Suhani Dalal, Ahish Chitneni, Anand Patil, Amnon A. Berger, Syed Mahmood, Vwaire Orhurhu, Alan D. Kaye, Jamal Hasoon

    Published 2022-05-01
    “…Specifically, serotonin noradrenaline reuptake inhibitors (SNRIs) have been used to treat a range of pain conditions expanding from everyday use for depressive disorders. # Recent Findings SNRIs, including duloxetine, venlafaxine, and milnacipran, have demonstrated efficacy in reducing pain in musculoskeletal pain (chronic low back pain and osteoarthritis), fibromyalgia, and neuropathic pain conditions (peripheral diabetic neuropathy)…”
    Get full text
    Article
  13. 173

    Adaptation of the Beck Anxiety Inventory in population of Buenos Aires by Nicolás Alejandro Vizioli, Alejandro Emilio Pagano

    Published 2020-09-01
    “…In its construction, one of the objectives was to evaluate anxiety symptoms that are not usually evident in depressive disorders, which is why it is a relevant test to make a differential diagnosis. …”
    Get full text
    Article
  14. 174

    Maternal mental disorders, psychotropic drugs, socioeconomic status, and offspring congenital anomalies by Satu-Maarit Björkstedt, Hannu Koponen, Hannu Kautiainen, Mika Gissler M, P. Pennanen, Johan G Eriksson, Merja K Laine

    Published 2025-01-01
    “…Results Severe depressive disorders were diagnosed in 2.0% of women and severe anxiety disorders in 1.1%. …”
    Get full text
    Article
  15. 175

    Cognitive Distortions in Depressed Women: Trait, or State Dependent? by Sedat BATMAZ, Sibel KOCBIYIK

    Published 2015-12-01
    “…Objective: According to the cognitive theory developed by Beck, cognitive distortions are important mediators for the onset and maintenance of depressive disorders. It has not been researched if these cognitive distortions are more frequently encountered during the depressive episode, or if they are trait-like features. …”
    Get full text
    Article
  16. 176

    An approach to teaching the psychiatric interview by Timothy Hierlihy, Andrew Latus

    Published 2025-01-01
    “…., discussing confidentiality, screening for suicidal ideation, taking a history for depressive disorders, etc.) before being assembled into a whole interview. …”
    Get full text
    Article
  17. 177

    Combined Dexamethasone Suppression-Corticotropin-Releasing Hormone Stimulation Test in Studies of Depression, Alcoholism, and Suicidal Behavior by Leo Sher

    Published 2006-01-01
    “…Considerable evidence suggests that HPA dysregulation is involved in the pathogenesis of depressive disorders, alcoholism, and suicidal behavior. …”
    Get full text
    Article
  18. 178

    Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders by Justin A. Barterian, Erin Rappuhn, Erin L. Seif, Gabriel Watson, Hannah Ham, John S. Carlson

    Published 2014-01-01
    “…In this review, the current state of evidence is presented for medications used to treat preschool children (ages 2–5 year olds) diagnosed with anxiety and/or depressive disorders. Eleven studies were systematically identified for this review based on a priori criteria. …”
    Get full text
    Article
  19. 179

    Research on treatment-related aspects of depression from India in the preceding decade (2014–2023): An updated systematic review by Alankrit Jaiswal, S Umesh, Nishant Goyal

    Published 2023-11-01
    “…Background: The National Mental Health Survey reports a prevalence of 2.7% for depressive disorders in India. The services for depression patients may be organized differently in India as compared to Western countries. …”
    Get full text
    Article
  20. 180

    Prevalence of depression in visually impaired children and adolescents: A systematic review and meta-analysis by Ajay Kumar Bakhla, Puja Pallavi, Ravi Rohan Kisku, Nishant Goyal, Amit Kumar, Kameshwar Prasad

    Published 2023-04-01
    “…Five studies that expressed gender distribution showed a cumulative prevalence of diagnosed depressive disorders was 6.85% and 18.96%, respectively, for male (n = 219, I2 = 47.52) and female (n = 116, I2 = 60.6%) participants. …”
    Get full text
    Article